Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
US9376418B2 · kind B2 · utility
1Cited by
22References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 17, 2013 |
| Grant date | Jun 28, 2016 |
| Priority date | — |
| Expiry date | Jun 30, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides certain substituted pyridines of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, Rcy, Cy, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.